Valuation: TELCON RF PHARMACEUTICAL. Inc.

Market Cap 12.79B 9.54M 8.5M 7.93M 7.23M 13.59M 919M 13.68M 95.76M 37.25M 469M 35.82M 35.04M 1.51B P/E 2024
-2.64x
P/E 2025 -3.84x
Enterprise Value 14.93B 11.14M 9.93M 9.26M 8.44M 15.87M 1.07B 15.98M 112M 43.5M 547M 41.82M 40.91M 1.76B EV / Sales 2024
3.07x
EV / Sales 2025 1.51x
Free-Float
83.87%
Yield 2024 *
-
Yield 2025 -
07-14 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-05 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-02 KPM TECH Co., Ltd. announced that it expects to receive KRW 22.499999595 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-17 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 3 billion in funding from Nuon Co., Ltd. CI
04-16 KPM TECH Co., Ltd. announced that it has received KRW 7.9999997 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-06 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 3 billion in funding from Nuon Co., Ltd. CI
04-06 KPM TECH Co., Ltd. announced that it expects to receive KRW 7.999999854 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
23/05/25 Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won RE
21/04/25 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
20/04/25 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
17/03/25 TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt CI
22/12/24 ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
11/12/24 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 2.5 billion in funding CI
1 day-0.66%
1 week+4.12%
Current month+4.84%
1 month+2.02%
3 months+8.59%
6 months-73.11%
Current year-75.19%
1 week 2,055
Extreme 2055
2,470
1 month 2,050
Extreme 2050
2,470
Current year 1,700
Extreme 1700
11,500
1 year 1,700
Extreme 1700
13,210
3 years 1,700
Extreme 1700
44,333.33
5 years 1,700
Extreme 1700
127,666.67
10 years 1,700
Extreme 1700
648,333.33
Manager TitleAgeSince
Chief Executive Officer 56 31/10/2017
Director of Finance/CFO 50 27/03/2019
Corporate Officer/Principal 54 29/03/2022
Director TitleAgeSince
Director/Board Member 50 27/03/2019
Director/Board Member 49 27/03/2019
Director/Board Member 56 31/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/08/25 ExerciceCompany 1,111,280 4.8639%
20/08/25 ConversionCompany 1,111,280 4.8639%
30/07/25 FreeCompany 2,222,560 18.4828%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+4.12%-79.90%-91.07% 9.5M
+0.55%+5.74%+66.11%+111.08% 442B
-0.22%+0.17%+42.20%+344.87% 262B
-0.38%-4.59%-11.83%+195.43% 172B
-0.56%-9.76%+100.27%+877.39% 142B
+0.58%+15.93%+566.42%+2,434.64% 97.36B
+1.78%-0.33%+0.55%+66.05% 74.04B
-2.55%+0.44%+121.08%+165.32% 59.28B
-0.42%+9.18%+157.31%+756.84% 55.5B
+1.55%-2.93%+11.07%+174.27% 54.22B
Average +0.09%+1.05%+97.33%+503.48% 135.85B
Weighted average by Cap. +0.21%+0.83%+91.40%+442.18%

Financials

2024 2025
Net sales 37.87B 28.25M 25.18M 23.48M 21.39M 40.25M 2.72B 40.52M 284M 110M 1.39B 106M 104M 4.47B 43.16B 32.2M 28.7M 26.76M 24.39M 45.88M 3.1B 46.18M 323M 126M 1.58B 121M 118M 5.1B
Net income -26.32B -19.63M -17.5M -16.32M -14.87M -27.98M -1.89B -28.16M -197M -76.67M -965M -73.72M -72.12M -3.11B -11.46B -8.55M -7.62M -7.1M -6.47M -12.18M -823M -12.26M -85.78M -33.37M -420M -32.09M -31.39M -1.35B
Net Debt 45.65B 34.06M 30.36M 28.31M 25.79M 48.53M 3.28B 48.85M 342M 133M 1.67B 128M 125M 5.39B 2.14B 1.6M 1.43M 1.33M 1.21M 2.28M 154M 2.29M 16.05M 6.24M 78.58M 6M 5.87M 253M
Logo TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
Employees
126
Date Price Change Volume
02/10/26 ₩2,275.00 -0.66% 66,405
01/10/26 ₩2,290.00 +5.53% 18,019
30/09/26 ₩2,170.00 +0.46% 31,072
29/09/26 ₩2,160.00 -1.82% 12,723
  1. Stock Market
  2. Stocks
  3. A200230 Stock